Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 259-265

  Ebert, Eileen ^a   Werle, Bernd ^a   Jülke, Britta ^a   Kopitar Jerala, Natasa ^b   Kos, Janko ^b   Lah, Tamara ^c   Abrahamson, Magnus ^d   Spiess, Eberhard ^e   Ebert, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; STEFIN A; STEFIN B;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0030814524     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_34     Document Type: Article

References (21)

1. Sloane, B. F., K. Moin, E. Krepela, and J. Rozhin. 1990. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Met. Rev. 9, 333-352.
2. Kane E., and M. M., Gottesman. 1990. The role of cathepsin L in malignant transformation. Semin. Cancer Biol. 1, 127-136.
3. Sloane B. F., K. Moin, and T. T. Lah. 1994. Regulation of lysosomal endopeptidases in malignant neoplasia. In G. Thomas, II. Pretlow, and Th. P. Pretlow, editors. Biochemical and molecular aspects of selected cancers, Academic Press, Toronto, Vol. 2, 411-466.
4. Turk V., and W. Bode. 1991. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
5. Lah T.T., J. L. Clifford, K. Helmer, N. Day, K. Mom, K. V. Honn, J. D. Crissman, and B. F. Sloane.1989. Inhibitory properties of low molecular weight cysteine proteinase inhibitors from human sarcoma. Biochim. Biophys. Acta 993, 63-73.
6. Calkins C. C., and B. F. Sloane. 1995. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol. Chem. Hoppe-Seyler 376, 71-80
7. Knoch H., B. Werle, W. Ebert, and E, Spiess. 1994. Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol. 5, 77-85.
8. Kyllönen, A. P., M. Järvinen, V. K. Hopsu-Havu, A. Dorn, O. Räsänen, T. Larmi, and A. Rinne. 1984. The behaviour of small molecular cysteine proteinase inhibitors in lung cancers and in surrounding tissue. Acta. Histochem. 74, 109-113.
9. Pyykkönen K., T. Räsänen, M. Järvinen, R. Rinne, and O. Räsänen. 1996. Immunolocalization of cystatin A in different types of the lung carcinomas. In INTERNATIONAL COMMITTEE ON PROTEOLYSIS. editors, 11th International Conference on Proteolysis and Protein Turnover, p. 135, Turku.
10. World Health Organization: Histological classification of lung tumors, WHO, Geneva (1981).
11. Hermanek P., and L. Sobin. TNM Classification of malignant tumors. 1987 In INTERNATIONAL UNION AGAINST CANCER (UICC), edtors, Vol. 4, Springer Verlag, Berlin.
12. Werle B., W. Ebert, W. Klein, and E. Spiess. 1995. Assessment of Cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue Biol. Chem. Hoppe-Seyler 376, 157-164.
13. Kos J., A. Smid, M. Krasovec, B. Svetic, B. Lenarcic, I. Vrhovec, J Skrk, and Turk V. 1995. Lysosomal proteases cathepsin D, B. H, L and their inhibitors stefins A and B in head and neck cancer Biol. Chem. Hoppe-Seyler 376, 401-405.
14. Olafsson I., H. Löfberg, M. Abrahamson, and A. Grubb, 1988. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand. J. Lab. Invest. 48, 573-582.
15. Bradford M. M. 1976. A rapid and sensitive method for the quantitation of microgramm quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
16. Kaplan E.L., and Meier P. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
17. Abel U., J. Berger, and H. Wiebelt. 1984. Critlevel. An exploratory procedure for the evaluation of quantitative prognostic factors Methods Inf. Med. 23, 154-156.
18. Budihna M., P. Strojan, L. Smid, J. Skrk, I. Vrhovec, A. Zupevc, Z. Rudolf, M. Zargi, M. Krasovec, B. Svatic, N. Kopitar-Jerala, and J. Kos. 1996. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefin A and B in head and neck carcinoma Biol. Chem. Hoppe-Seyler 377, 385-390.
19. Sheahan K., S. Shuja, and M. J. Murnane. 1989. Cysteine protease activities and tumor development in human colorectal carcinomas. Cancer Res 49, 3809-3814.
20. Lah T.T., M. Kokalj-Kunovar, B. Strkelj, J. Pungercar, D. Barlic-Maganja, M. Drobnic-Kosorok, L. Kastelic, J. Babnik, R. Golouh, and V. Turk. 1992. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int. J. Cancer 50, 36-44.
21. Mountain C.F. 1991. Surgical treatment of lung cancer. Critic. Rev. Oncol./Hematol. 11, 179-207.